Latest News about CCC
Recent news which mentions CCC
Cannabinoid Treatment Significantly Reduces Fibromyalgia Pain And Improves Quality Of Life, New Tilray-Backed Study Finds
September 09, 2024
From Benzinga
First Weed Shop In North Carolina, Why Are D.C. Medical Marijuana Shops Closing Down? More New Places To Buy Legal Cannabis
September 06, 2024
From Benzinga
Leadership Shake-Ups In Cannabis And Psychedelics: Maryland's Cannabis Chief Resigns, Costly Legal Battle In MA Drags On & More
September 06, 2024
From Benzinga
New Hope For Alabama Medical Marijuana Program As Judge Considers Revising Licensing Restrictions
September 05, 2024
From Benzinga
Are Banks Ready To Serve The Cannabis Industry? What One Expert Says About The Future
September 05, 2024
Tickers
CCC
From Benzinga
Irish Biotech Firm GH Research Sees Cash Decline in Q2, Advances Psychedelic Drug Trials
September 05, 2024
From Benzinga
Hollywood Star Jim Belushi Brings Cannabis Expertise To Chicago Conference In October
September 04, 2024
From Benzinga
Boomerang Effect: Ignoring Delta-8 THC Regulations Could 'Take Off A Lot Of Heads,' Expert Warns
September 04, 2024
From Benzinga
From Benzinga
The Overlooked Power Of Hemp: Ross Gerber Discusses Legal, Economic Benefits
September 03, 2024
From Benzinga
Billion-Dollar Cannabis Company Closes Acquisition Of Three US Breweries, What's Next For Tilray
September 03, 2024
From Benzinga
Cannabis Joint Venture Secures Major Florida Deal Amid Trump Endorsement Of Marijuana Legalization
September 03, 2024
From Benzinga
Tobacco Giant Invests $30.8M In Cannabis Company: BAT Private Placement Second Of Three Tranches
September 03, 2024
From Benzinga
EXCLUSIVE: Investor Ross Gerber On How Cannabis Rescheduling Could Slash Costs For Companies
September 03, 2024
Tickers
CCC
From Benzinga
From Benzinga
Canadian Cannabis Processor Nextleaf Reports 50% YoY Revenue Boost, Remains Debt-Free, Focused On Innovation
August 30, 2024
From Benzinga
U.S. Cannabis Companies Struggle With Institutional Capital, While Europe Thrives, Says Expert
August 30, 2024
Tickers
CCC
From Benzinga
National Cannabis Roundtable Applauds DEA's Move: December Hearing On Rescheduling Set
August 30, 2024
From Benzinga
Red Light Holland Q1 Revenue Spikes Nearly 30% YoY, Focuses On Strategic Profitability
August 30, 2024
From Benzinga
From Benzinga
Marijuana Rescheduling Is Not Solution To Industry's Banking Issues, Congressional Researchers Say And More Cannabis Regs
August 29, 2024
From Benzinga
SNDL Wins Bid For Indiva, Secures Major Deal To Boost Cannabis Edibles Market Share In Canada
August 29, 2024
From Benzinga
Financial Roadblocks In Cannabis: What's Hindering Growth And How To Fix It According To Experts
August 29, 2024
Tickers
CCC
From Benzinga
From Benzinga
Avicanna Secures Nearly $2M In Private Placement Deal Amid US Patent Win For Cannabinoid Topical Formula
August 29, 2024
From Benzinga
Congressman Blumenauer Slams DEA For Postponing Marijuana Rescheduling, Places Hope In Soon-To-Be President Harris
August 28, 2024
From Benzinga
Greenway Cannabis Co. Doubles Q1 Net Revenue YoY, Highest Adjusted EBITDA Results To Date
August 28, 2024
From Benzinga
Harris-Walz Ticket Could Be 'A Tremendous Asset' For Cannabis Reform, But Senate Hurdles Remain, Says Expert
August 28, 2024
Tickers
CCC
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.